Both in Pharmaceuticals
Apnimed vs Design Therapeutics
| Metric | APMD | DSGN |
|---|---|---|
| Price | $18.65 | $11.97 |
| Market cap | $776.4M | $749.1M |
| Today | −14.25% | −3.62% |
| 1 month | — | −20.9% |
| 6 months | — | −2.0% |
| Year to date | — | +27.6% |
| 1 year | — | +95.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 49.3% |
| Short % of float | — | 21.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).